Novo Nordisk aware of 10 deaths related to weight-loss drug copies - report

featured-image

Carolina Rudah/iStock via Getty Images Novo Nordisk ( NVO ) is aware of 10 deaths and 100 hospitalizations of people that took copycat versions of its popular drugs Wegovy and Ozempic, its CFO Karsten Munk Knudsen told a media briefing on Wednesday, as reported by Reuters . The drugmaker "identified multiple safety.